8. CLINICAL PHARMACY

Written and reviewed by Dr. N. Sujith Kumar | Pharm.D Graduate from JNTUK | D.Pharmacy Academic Content Creator

CLINICAL PHARMACY: A TEACHER’S COMPREHENSIVE GUIDE

Welcome, future clinical pharmacists and healthcare professionals!

Clinical Pharmacy is the branch of pharmacy that is concerned with patient care, dispensing of drugs, and advising patients about the safe and rational use of medications. It represents the shift from a product-oriented to a patient-oriented profession—where pharmacists actively participate in patient care, optimize drug therapy, and improve health outcomes.

As a pharmacy educator with years of experience teaching clinical pharmacy, I have observed that students often struggle to understand the breadth and depth of this specialty. Clinical pharmacy is not just about dispensing medications—it is about ensuring that every patient receives the right drug, at the right dose, through the right route, at the right time, with the right monitoring. It is the pharmacist’s active participation in patient care with the long-term aim of tailoring drug therapy for each individual patient.

In this comprehensive guide, I will walk you through the scope, roles, daily activities, and advanced concepts of clinical pharmacy practice—from patient medication histories and ward round participation to pharmaceutical care and medication therapy management. By the end of this article, you will have a thorough understanding of what it means to be a clinical pharmacist and how this specialty transforms patient care. Let us begin our journey into the heart of patient-centered pharmacy practice.

Dpharmguru’s exam insights:

Clinical pharmacy is one of the most important topics in pharmacy exams. Remember: Clinical pharmacy is defined as “the active participation of the pharmacist in patient care with the long-term aim of giving advice on medication with an individual patient in mind and tailoring drug therapy for that individual.” Key concepts include: patient medication histories, rational prescribing, adverse drug reaction monitoring, ward round participation, pharmaceutical care, and Medication Therapy Management (MTM). Pay special attention to the daily activities of clinical pharmacists—they are frequently tested!

8.1. DEFINITION AND SCOPE OF CLINICAL PHARMACY

8.1.1. Definition

Clinical Pharmacy is the branch of pharmacy which is concerned with patient care, dispensing of drugs, and advising patients about safe and rational use of drugs. This is a health specialty which describes the activities and services of the clinical pharmacist to develop and promote the rational and appropriate use of medicinal products and devices.

Clinical pharmacy is also defined as “the active participation of the pharmacist in patient care with the long-term aim of giving advice on medication with an individual patient in mind and tailoring drug therapy for that individual.”

8.1.2. Scope of Clinical Pharmacy

A clinical pharmacist has many scopes. Some of them are stated below:

  • Preparation of Patient Medication Histories: The pharmacist summarises a patient case using the patient medication history and submits it to the physician before diagnosis. This minimises the time and efforts of the physician and helps in faster and effective drug therapy selection.
  • Rational Prescription: A clinical pharmacist helps the physician in selecting the right drug. Examples of irrational combinations include Haloperidol + Diazepam + Amitriptyline, and Reserpine + Sintamil.
  • Bioequivalence and Generic Equivalence: Every individual responds differently to drugs. Clinical pharmacists help in selecting proper drug therapy based on bioequivalence studies on different dosage forms.
  • Patient Monitoring: Clinical pharmacists observe signs and symptoms, monitor drug therapy for safety and efficacy, and detect overdosage signs and contraindications.
  • Adverse Drug Reactions and Drug Interactions: Clinical pharmacists collect and process data, advise alternate therapy, and recognise drug effect modifications caused by interactions with foods, alcohol, smoking, and environmental chemicals.
  • Drug Diagnostic Test Inferences: Clinical pharmacists identify alterations in test results due to drugs and prevent inaccurate diagnosis due to faulty interpretation.
  • Intravenous Admixtures: Clinical pharmacists prepare IV admixtures under aseptic conditions, calculate drug doses and administration rates, monitor incompatibilities, and formulate total parenteral fluids.
  • Drug Information Specialist: Clinical pharmacists operate drug information services, communicate drug-related information, provide assistance during medical emergencies, and offer immediate information on antidotes.
  • Retail Pharmacy Stores: Clinical pharmacists retain patient drug profiles, counsel patients during prescription filling, and advise in selecting OTC drugs while considering interactions with prescription medications.
  • Discharge Counselling and Patient Compliance: Clinical pharmacists improve drug therapy compliance through educating and counselling patients at discharge or at the retail counter.
  • Clinical Research and Continuing Education: Clinical pharmacists participate in evaluation programmes on new drugs, carry out clinical trials, and arrange training programmes for pharmacists, nurses, and interns.
  • Medical Audit: Clinical pharmacists work as initiators or active members of medical audit committees, reviewing legislation, pharmacotherapy orders, formulary policy, and drug use patterns.

8.1.3. Roles of Clinical Pharmacist

  • Supervises drug distribution related activities to ensure controlled use of drug and patient safety.
  • Opts for therapeutically effective drug products at reasonable cost.
  • Records patient’s medication history including drugs prescribed earlier and any adverse reactions.
  • Detects and diagnoses adverse drug reactions and drug interactions.
  • Does patient counselling on use of drugs to assure compliance.
  • Helps patients in selecting OTC drugs.
  • Frames dosage regimens for patients.
  • Encourages rational drug therapy.
  • Deals with psycho-socio-economic aspects of healthcare.
  • Participates in the management of patients having acute and chronic diseases.
  • Detects and corrects incompatibilities observed in drug mixtures.
  • Prepares patient-specific drug formulations.
  • Directs dispensing assistants in dispensing of prescriptions.
  • Evaluates drug literature.
  • Reviews drug utilisation.
  • Promotes healthcare knowledge in public.
  • Prescribes drugs to patients having mild and self-limiting diseases.
  • Monitors how patients respond to drugs using patient medicine profiles.

Dpharmguru’s exam insights:

The roles of a clinical pharmacist are frequently tested. Remember: Clinical pharmacists are patient-centered professionals who participate in direct patient care. They supervise drug distribution, detect adverse reactions, counsel patients, encourage rational therapy, and participate in management of acute and chronic diseases. The shift from product-oriented to patient-oriented practice is the key philosophy!

8.1.4. Development of Clinical Pharmacy

In India

  • Clinical pharmacy services were first offered in India in 1992 when B. Suresh and B.G. Nagavi contacted clinical pharmacist Frank May in Australia.
  • In 1997, clinical pharmacy practise programmes were implemented at hospitals in Mysore and Ooty.
  • Government sector and private sector models were created as two model centres for clinical pharmacy practise.
  • Institutions offering clinical pharmacy degrees include: Shri Sarvajanik Pharmacy College (Gujarat), R.C. Patel College of Pharmacy (Maharashtra), NMIMS University (Maharashtra), ICRI, CREMA, Jamia Hamdard, and DIPSAR (New Delhi).
  • Clinical pharmacy activities are now taking place in cities like Bangalore, Belgaum, Chennai, Cochin, Coimbatore, Manipal, and Trichur.

In Other Countries

  • United Kingdom: Graham Calder created ward pharmacy services in Aberdeen; John Baker developed the formulary concept at Westminster Hospital.
  • United States: Harvey A.K. Whitney, Paul Parker, and Eugene White pioneered pharmacy practice innovations.
  • Key Milestones: Patient medication profiles (1960), Drug Information Center (1962), IDIS (1965), CDTM (1977), all Pharm.D. Program (1992), and pharmacists on transplant teams (2004).

8.2. TECHNICAL DEFINITIONS AND COMMON TERMINOLOGIES USED IN CLINICAL PHARMACY

8.2.1. Common Medical Specialties

Medical SpecialitySignificance
CardiologyStudy of the heart, its functions and diseases
DermatologyStudy of skin, nails, and hair diseases
EndocrinologyStudy of endocrine glands, their secretions and diseases
GastroenterologyStudy of alimentary tract diseases
GeriatricsStudy and treatment of old age and its manifestations
GynaecologyStudy of diseases in women
HaematologyStudy of blood and blood-forming organs
NeurologyStudy of nervous system diseases
ObstetricsStudy of women during pregnancy and child birth
OphthalmologyStudy of the anatomy, physiology and diseases of the eye
OrthopaedicsBranch of surgery dealing with abnormalities, diseases and injuries of bones
PaediatricsStudy of diseases in babies and children
PathologyScience of diseases and their effects on body tissues
PharmacyPractice of preparation of medicines
PhysiologyStudy of normal functions of the human body
PsychiatryStudy of mind diseases

8.2.2. Common Medical Terminologies

TerminologyDefinition
AetiologyThe cause of a disease
AnaphylaxisHypersensitivity to foreign proteins
AntenatalBefore birth
AntibodySubstance exerting destructive action on compounds or bacteria
AntisepticSubstance destroying micro-organisms
AtherosclerosisFatty degeneration and hardening of arteries
BradycardiaSlower heart rate than normal
CongenitalExisting before birth, in-born error
EmbolusDetached blood clot
HaematuriaBlood in urine
HepatitisInflammation of liver
HyperglycemiaToo high blood sugar
IatrogenicDrug or treatment-induced abnormal state
ImmunityResistance of a body to the effects of a deleterious agent
MicturitionPassage of urine, urination
OsteoporosisSoftening of bone
PathogenicDisease causing
PathologyThe study of causes and changes of diseases
PlaceboInert substance given for experimental purposes
ProphylaxisSteps taken for prevention
ToxinNoxious or poisonous substance

8.2.3. Latin Abbreviations

AbbreviationLatinMeaning
a.c.ante cibumBefore meals
alt. h.alternis horisEvery other hour
a.m.ante meridiemMorning, before noon
bisbisTwice
b.i.d.bis in dieTwice daily
ccibosFood
h, hrhoraHour
h.s.hora somniAt bedtime
noctnocteAt night
p.c.post cibumAfter meals
p.m.post meridiemEvening or afternoon
prnpro re nataAs needed
p.o.per osBy mouth or orally
q.d.quaque dieEvery day
t.i.d.ter in dieThree times a day

8.3. DAILY ACTIVITIES OF CLINICAL PHARMACISTS

Following are the daily activities that a clinical pharmacist must perform:

  • Ward round participation
  • Treatment chart review
  • Adverse drug reaction monitoring
  • Drug information and poisons information
  • Medication history
  • Patient counselling
  • Inter-professional collaboration

8.3.1. Ward Round Participation

A visit made to hospital in-patients at their bedside by a medical practitioner (either alone or with a team of health professionals and medical students) to review and follow-up the progress in their health is termed as a ward round.

Goals for Clinical Pharmacists on Ward Round:

  • To understand the patients’ clinical status, progress, planned investigations, and therapeutic goals.
  • To provide appropriate information on pharmacology, pharmacokinetics, drug availability, cost, interactions, and adverse reactions.
  • To optimise therapeutic management by influencing drug therapy selection, implementation, monitoring, and follow-up.
  • To investigate drug orders or doses.
  • To collect supplementary information about comorbidities, medication compliance, or alternative medicine use.
  • To detect adverse drug reactions and drug interactions.
  • To participate in patient discharge planning.

Classification of Ward Rounds:

  • Pre-rounds: Patients reviewed by interns or medical postgraduate students, sometimes accompanied by trainee clinical pharmacists.
  • Registrar/Resident Rounds: Conducted daily at a fixed time by registrars and residents, involving clinical teaching.
  • Professor/Chief Rounds: Conducted by the chief of a unit or professor, addressing complex issues in diagnosis or management.
  • Teaching Rounds: Academic medical staff conducts bedside clinical teaching for students, useful for improving clinical knowledge.

8.3.2. Treatment Chart Review

Treatment chart review is a process in which a pharmacist evaluates a patient’s medication regimen while admitted to the hospital. This procedure entails assessing the therapeutic efficacy of each medication and the progression of disorders being treated.

Goals:

  • To teach clinical pharmacy students how to assess and comprehend a drug record.
  • To define objectives based on the health of the patient and intervene at the appropriate moment.
  • To teach students about continuity of care by involving them in treatment decision-making, patient monitoring, dispensing medicine, and offering medication information counselling.
  • To teach students how to establish rapport with clinical team members.

8.3.3. Adverse Drug Reaction Monitoring

An Adverse Drug Reaction (ADR) is any appreciable harmful or unpleasant reaction resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen or withdrawal of the product.

What to Report:

  • All ADRs resulting from prescription and OTC medications.
  • All suspected ADRs, regardless of the product details.
  • Unanticipated reactions to the product.
  • A marked rise in the frequency of a certain reaction.
  • Serious responses, whether anticipated or not.
  • Any probable ADRs related to interactions between foods, drugs, or both.
  • ADRs brought on by medication errors or overdoses.

8.3.4. Drug Information and Poisons Information

Drug information is the knowledge about drugs assembled in written forms or transmitted by oral communication or by electronic device of the physical, chemical, biological, and health care sciences.

Poison information is a specialised area of drug information that covers information on toxic effects of chemicals, pesticides, hazardous material spills, household items, overdoses of therapeutic drugs, mushrooms, and animal toxins.

Dpharmguru’s exam insights:

Drug information services are a core function of clinical pharmacy. Remember: MEDLARS (1964) and MEDLINE (1971) are key drug information retrieval systems. Drug information is provided in response to inquiries from other healthcare professionals, organisations, patients, committees, or members of the public. It is a fundamental service that improves patient safety and optimises drug use.

8.3.5. Medication History

Patient medication history interview involves evaluating and interviewing patients about their past and current use of drugs in order to collect and record information. Usually, clinical pharmacists are responsible for this type of activity.

Goals:

  • To discover more about a patient’s drug consumption to enable pharmacists in providing better overall care.
  • To assist in identifying medication inconsistencies by comparing the drug profile with the medication administration data.
  • To help in documenting adverse drug reactions, including allergic reactions.
  • To help in determining the rationale for drug prescriptions, indications of drug abuse, and examining drug interactions.
  • To help in evaluating the techniques for drug administration and determining the need for pharmacological help.

8.3.6. Patient Counselling

Patient counselling is the process in which the pharmacist gives information orally and/or using written materials and advises the patients or their caretaker regarding the proper use of medications. This information includes information on drug usage and even lifestyle changes.

Goals:

  • To provide a better knowledge of illness and the role of medication to the patient.
  • To improve medication compliance.
  • To make drug treatment more effective.
  • To reduce the chances of adverse effects and unnecessary expenditure on healthcare.
  • To improve patient’s quality of life.
  • To provide better strategies to overcome medication-related adverse effects.
  • To maintain a better professional relationship between the pharmacist and patient.

8.3.7. Interprofessional Collaboration

Interprofessional Collaboration can be defined as the collaboration of two or more professions to achieve common goals and solve various complicated issues. There are various types of collaborations, such as healthcare collaboration, collaborative learning, research and funding collaboration, etc.

Goals:

  • To collaborate with the multidisciplinary pathway team to provide evidence-based, patient-centered therapeutic regimens.
  • To align clinical pathways with formulary decisions by the Pharmacy and Therapeutics Committee.
  • To provide pilot pharmaceutical services such as medication reconciliation within 24 hours of admission and patient counseling before discharge.
  • To design effective tools to implement perspectives such as the integration of order sets into Computerised Physician Order Entry (CPOE).
  • To communicate with healthcare professionals effectively to enhance the implementation of these tools.
  • To identify opportunities within the pathway team to optimise the cost-effective use of medications.
  • To provide continuous education to pharmacy staff and other healthcare professionals.

8.3.8. Therapeutic Drug Monitoring (TDM)

Therapeutic Drug Monitoring can be defined as measuring the amount of drugs in the body fluids which is aimed at optimising the drug therapy of patients. It is the tool utilised to modify the dosage regimen by maintaining its concentration in the blood/plasma within the therapeutic window.

Criteria for Drugs Used in TDM:

  • It should have a narrow therapeutic window.
  • It should have physiological parameters that cannot be easily measured.
  • It should exhibit non-linear kinetics.
  • It should not be easily absorbed.

Dpharmguru’s exam insights:

Therapeutic Drug Monitoring is a frequently tested topic. Remember: Drugs with narrow therapeutic windows require TDM. Examples include: aminoglycosides, digoxin, lithium, phenytoin, theophylline, and cyclosporine. TDM helps optimise dosage regimens, avoid toxicity, and ensure therapeutic efficacy. The therapeutic window is the range between the minimum effective concentration and the minimum toxic concentration.

8.4. PHARMACEUTICAL CARE

8.4.1. Definition of Pharmaceutical Care

Pharmaceutical care can be defined as the practice in which a practitioner is accountable for the drug-related needs of a patient. According to the Pharmaceutical Care Network Europe (PCNE), “Pharmaceutical Care is the pharmacist’s contribution to the care of individuals in order to optimise medicines use and improve health outcomes.”

8.4.2. Classification of Drug-related Problems

Drug-related Problems (DRPs) are situations that may have an impact on a patient’s health. DRPs can happen at any point during the administration of a medicine, from the time it is prescribed to the time it is dispensed.

Common DRPs include:

  • Untreated indications
  • Improper drug selection
  • Sub-therapeutic dosage
  • Overdosage
  • Adverse drug reactions
  • Drug interactions
  • Failure to receive medication
  • Continuing medication use for a condition that has resolved

8.4.3. Principles to Provide Pharmaceutical Care

  • Knowledge and skills of personnel
  • Systems for data collection, documentation and transfer of information
  • Effective workflow techniques
  • References, equipment and resources
  • Communication skills
  • A commitment to techniques for evaluating and enhancing quality
  • Patient-centered approach

8.5. MEDICATION THERAPY MANAGEMENT (MTM)

Medication Therapy Management is a specific service or set of services which maximises therapeutic results for certain patients. These services are separate from the provision of a medication product but may coexist with it.

8.5.1. Goals of MTM

  • To offer MTM services in every area of care where patients get medicine.
  • To ensure that the patient receives the medication that is best suited to his/her health conditions.
  • To make MTM services useful for anybody who takes herbal remedies, OTC medicines, or prescription pharmaceuticals.
  • To help those who use several drugs, have multiple health conditions, or get their prescriptions from multiple pharmacies.

8.5.2. Services Provided by MTM

  • Making or acquiring essential evaluations of patient’s health situation.
  • Creating a treatment plan for medications.
  • Choosing, starting, adjusting, or giving drug therapy.
  • Tracking and assessing the patient’s response to treatment.
  • Conducting a thorough medication review to find, fix, and avoid medication-related issues.
  • Recording the care provided and informing the patient’s other primary care providers.
  • Giving verbal instruction and training aimed at improving patient comprehension and proper drug usage.

8.5.3. Benefits of MTM

  • Better drug adherence and use by patients.
  • A higher proportion of patients achieving their treatment objectives.
  • Minimised drug crossover, negative side effects, or interactions.
  • Greater cost savings on medicine and medical resources.

8.6. HOME MEDICATION REVIEW (HMR)

Home Drug Review (HMR) was created to help consumers who live at home make the most of their medication regimen and avoid medication-related issues. It is a customer-focused, organised, and cooperative service provided to customers living at home in the community.

8.6.1. Goals of HMR

  • To improve the patient’s medication compliance and medication knowledge.
  • To recognise the causes of non-compliance.
  • To review the patient’s regimen for taking medications at home.
  • To decrease wastage due to over-stocking of medicines.
  • To enhance the quality of life for the patient.

8.6.2. Need of HMR

It is a good idea to get an HMR if a person:

  • Takes more than 5 medications per day.
  • Is worried about the medicines.
  • Has trouble remembering to take medication or is confused sometimes.
  • Requires constant monitoring due to the medications they are taking.
  • Utilises medications that may interact negatively with other drugs.
  • Feels sick following medication use.
  • The medication is not making them feel better.
  • Has recently been hospitalized.
  • Has recently undergone medication modifications.

8.6.3. Benefits of HMR

  • Strengthening the bonds between patients and pharmacists.
  • Greater health literacy among patients at high risk.
  • Elderly patients receive special attention.
  • Service that improves management education for self-medication.
  • Information about the pharmaceutical requirements for high-risk chronic patients.
  • Optimising the cost of medical treatment.

Dpharmguru’s exam insights:

Pharmaceutical Care, MTM, and HMR are advanced clinical pharmacy concepts that are increasingly tested in exams. Remember: Pharmaceutical care is about accountability for drug-related needs. MTM is a specific set of services to maximise therapeutic results. HMR is a home-based service for community patients. These concepts represent the evolution of pharmacy from a dispensing role to a patient-centered clinical role. Pay special attention to the goals and benefits of each!

COMPARISON: CLINICAL PHARMACY CONCEPTS

ConceptFocusSettingKey Activities
Pharmaceutical CarePatient accountabilityAll healthcare settingsDRP identification, therapy optimisation
MTMMedication optimisationCommunity & clinicalMedication review, care plans, monitoring
HMRHome medication reviewPatient’s homeHome interview, medication profile, GP referral
Ward RoundIn-patient careHospital wardsBedside review, drug therapy optimisation

FREQUENTLY ASKED QUESTIONS (FAQs)

1. What is the difference between clinical pharmacy and community pharmacy?

Clinical pharmacy focuses on patient-centered care in hospital settings, involving direct patient care, ward rounds, and therapeutic drug monitoring. Community pharmacy focuses on dispensing medications, providing OTC advice, and serving ambulatory patients. Clinical pharmacists are more involved in direct patient care and interprofessional collaboration.

2. What is the role of a clinical pharmacist in a hospital?

Clinical pharmacists participate in ward rounds, review treatment charts, monitor adverse drug reactions, provide drug information, take medication histories, counsel patients, and collaborate with the healthcare team to optimise drug therapy.

3. What is the difference between MTM and HMR?

MTM (Medication Therapy Management) is a set of services provided primarily to patients with multiple medications to optimise therapeutic outcomes. HMR (Home Medication Review) is a specific service conducted in the patient’s home, focusing on medication management and compliance for community patients.

4. What are the criteria for drugs used in TDM?

Drugs used in TDM should have a narrow therapeutic window, physiological parameters that cannot be easily measured, exhibit non-linear kinetics, and should not be easily absorbed. Examples include aminoglycosides, digoxin, lithium, phenytoin, theophylline, and cyclosporine.

5. What is the purpose of patient counselling in clinical pharmacy?

Patient counselling aims to provide better knowledge of illness and medication, improve medication compliance, make drug treatment more effective, reduce adverse effects, improve quality of life, and maintain a better professional relationship between the pharmacist and patient.

6. What is an adverse drug reaction (ADR)?

An ADR is any appreciable harmful or unpleasant reaction resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen or withdrawal of the product.

SUMMARY

Clinical pharmacy represents the evolution of pharmacy from a product-oriented to a patient-oriented profession. Clinical pharmacists are active participants in patient care—providing medication history reviews, ward round participation, drug information services, adverse drug reaction monitoring, patient counselling, and therapeutic drug monitoring.

The scope of clinical pharmacy is vast—from preparing patient medication histories and rational prescribing to bioequivalence studies, patient monitoring, and drug diagnostic test inferences. Advanced concepts like Pharmaceutical Care, Medication Therapy Management (MTM), and Home Medication Review (HMR) represent the future of pharmacy practice, where pharmacists are accountable for drug-related needs and actively collaborate with other healthcare professionals to optimise patient outcomes.

As I always tell my students: “Clinical pharmacy is not about dispensing—it is about caring. It is about using your knowledge of medicines to make a real difference in patients’ lives. The pharmacist’s role has evolved from preparing medicines to providing patient-centered care. Embrace this role, and you will transform healthcare.”

REFERENCES AND FURTHER READING

  • Pharmacy Council of India (PCI). (2022). Clinical Pharmacy Guidelines. New Delhi: PCI.
  • International Pharmaceutical Federation (FIP). (2022). Clinical Pharmacy Practice Standards. Retrieved from https://www.fip.org.
  • World Health Organization (WHO). (2022). Guidelines on Clinical Pharmacy Services. Retrieved from https://www.who.int.
  • American Society of Health-System Pharmacists (ASHP). (2022). Clinical Pharmacy Practice Standards. Retrieved from https://www.ashp.org.
  • Pharmaceutical Care Network Europe (PCNE). (2022). Classification of Drug-Related Problems. Retrieved from https://www.pcne.org.
  • Cousins, D. & Luscombe, D. (2021). Clinical Pharmacy: Evolution and Practice. Pharmaceutical Press.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Clinical pharmacy regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.

Dr. N. Sujith Kumar Avatar

written by:
Dr. N. Sujith Kumar

For More Study Materials, Visit: www.dpharmguru.com

Share your love

Leave a Reply

Your email address will not be published. Required fields are marked *